Insignia™ Hip Stem Outcomes Study
Insignia™ Hip Stem Outcomes Study - A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia™ Hip Stem for Total Hip Replacement Surgery
Sponsor: Stryker Orthopaedics
A NA clinical study on Avascular Necrosis and Femoral Neck Fractures, this trial is ongoing. The trial is conducted by Stryker Orthopaedics and has accumulated 9 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Jul 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Jul 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Dec 2023 — Jun 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Sep 2022 — Dec 2023 [monthly]
Recruiting NA
-
May 2022 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2022 — May 2022 [monthly]
Not Yet Recruiting NA
-
Jan 2022 — Feb 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Stryker Orthopaedics
For direct contact, visit the study record on ClinicalTrials.gov .